Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Mind Medicine

MindMed Scientific Presentations at American College of Neuropsychopharmacology (ACNP) 2024 Congress
From Mind Medicine
Via Business Wire
Tickers MNMD
MindMed Announces Constructive End-of-Phase 2 Meeting with U.S. FDA for MM120 in Generalized Anxiety Disorder (GAD)
From Mind Medicine
Via Business Wire
Tickers MNMD
MindMed to Present at Upcoming April Medical Conferences
From Mind Medicine
Via Business Wire
Tickers MNMD
MindMed Announces Positive Topline Results from Phase 2b Trial of MM-120 in Generalized Anxiety Disorder
From Mind Medicine
Via Business Wire
Tickers MNMD
MindMed Reports Third Quarter 2023 Financial Results and Business Highlights
From Mind Medicine
Via Business Wire
Tickers MNMD
MindMed Announces Election of All Six Company Nominees at Annual Meeting
From Mind Medicine
Via Business Wire
Tickers MNMD
MindMed Provides Overview of Clinical Progress and Corporate Updates at Investor Day
From Mind Medicine
Via Business Wire
Tickers MNMD
MindMed Adjourns Annual General Meeting of Shareholders
From Mind Medicine
Via Business Wire
Tickers MNMD
MindMed to Host Investor Day June 2023
From Mind Medicine
Via Business Wire
Tickers MNMD
MindMed to Participate at Upcoming Investor Conferences
From Mind Medicine
Via Business Wire
Tickers MNMD
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.